Advancements in Bone Replacement Techniques-Potential Uses After Maxillary and Mandibular Resections Due to Medication-Related Osteonecrosis of the Jaw (MRONJ)

Overview

Journal Cells

Publisher MDPI

Date 2025 Jan 24

PMID 39851573

Authors

Judit Bovari-Biri

Judith A Miskei

Zsanett Kover

Alexandra Steinerbrunner-Nagy

Kinga Kardos

Peter Maroti

Judit E Pongracz

Affiliations

Soon will be listed here.

Abstract

Maxillofacial bone defects can have a profound impact on both facial function and aesthetics. While various biomaterial scaffolds have shown promise in addressing these challenges, regenerating bone in this region remains complex due to its irregular shape, intricate structure, and differing cellular origins compared to other bones in the human body. Moreover, the significant and variable mechanical loads placed on the maxillofacial bones add further complexity, especially in cases of difficult-to-treat medical conditions. This review provides a brief overview of medication-related osteonecrosis of the jaw (MRONJ), highlighting the medication-induced adverse reactions and the associated clinical challenges in treating this condition. The purpose of this manuscript is to emphasize the role of biotechnology and tissue engineering technologies in therapy. By using scaffold materials and biofactors in combination with autologous cells, innovative solutions are explored for the repair of damaged facial bones. The ongoing search for effective scaffolds that can address these challenges and improve in vitro bone preparation for subsequent regeneration in the maxillofacial region remains critical. The primary purpose of this review is to spotlight current research trends and novel approaches in this area.

References

Pilmane M, Salma-Ancane K, Loca D, Locs J, Berzina-Cimdina L . Strontium and strontium ranelate: Historical review of some of their functions. Mater Sci Eng C Mater Biol Appl. 2017; 78:1222-1230. DOI: 10.1016/j.msec.2017.05.042. View

Plotkin L, Aguirre J, Kousteni S, Manolagas S, Bellido T . Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular mechanisms downstream of extracellular signal-regulated kinase activation. J Biol Chem. 2004; 280(8):7317-25. DOI: 10.1074/jbc.M412817200. View

Fan H, Kim S, Cho Y, Eo M, Lee S, Woo K . New approach for the treatment of osteoradionecrosis with pentoxifylline and tocopherol. Biomater Res. 2015; 18:13. PMC: 4552457. DOI: 10.1186/2055-7124-18-13. View

Otsuki L, Tanaka E . Positional Memory in Vertebrate Regeneration: A Century's Insights from the Salamander Limb. Cold Spring Harb Perspect Biol. 2021; 14(6). PMC: 9248832. DOI: 10.1101/cshperspect.a040899. View

Bakhshandeh B, Ranjbar N, Abbasi A, Amiri E, Abedi A, Mehrabi M . Recent progress in the manipulation of biochemical and biophysical cues for engineering functional tissues. Bioeng Transl Med. 2023; 8(2):e10383. PMC: 10013802. DOI: 10.1002/btm2.10383. View

Fuchs A, Youssef A, Seher A, Hochleitner G, Dalton P, Hartmann S . Medical-grade polycaprolactone scaffolds made by melt electrospinning writing for oral bone regeneration - a pilot study in vitro. BMC Oral Health. 2019; 19(1):28. PMC: 6359770. DOI: 10.1186/s12903-019-0717-5. View

Misch C, Qu Z, Bidez M . Mechanical properties of trabecular bone in the human mandible: implications for dental implant treatment planning and surgical placement. J Oral Maxillofac Surg. 1999; 57(6):700-6; discussion 706-8. DOI: 10.1016/s0278-2391(99)90437-8. View

Barat-Houari M, Dumont B, Fabre A, Them F, Alembik Y, Alessandri J . The expanding spectrum of COL2A1 gene variants IN 136 patients with a skeletal dysplasia phenotype. Eur J Hum Genet. 2015; 24(7):992-1000. PMC: 5070901. DOI: 10.1038/ejhg.2015.250. View

Li S, Cui Y, Liu H, Tian Y, Wang G, Fan Y . Application of bioactive metal ions in the treatment of bone defects. J Mater Chem B. 2022; 10(45):9369-9388. DOI: 10.1039/d2tb01684b. View

10.

Chan B, Leong K . Scaffolding in tissue engineering: general approaches and tissue-specific considerations. Eur Spine J. 2008; 17 Suppl 4:467-79. PMC: 2587658. DOI: 10.1007/s00586-008-0745-3. View

11.

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

12.

Vo T, Kasper F, Mikos A . Strategies for controlled delivery of growth factors and cells for bone regeneration. Adv Drug Deliv Rev. 2012; 64(12):1292-309. PMC: 3358582. DOI: 10.1016/j.addr.2012.01.016. View

13.

Stewart M . Aflibercept (VEGF-TRAP): the next anti-VEGF drug. Inflamm Allergy Drug Targets. 2011; 10(6):497-508. DOI: 10.2174/187152811798104872. View

14.

Deng Z, Li Y, Gao X, Lei G, Huard J . Bone morphogenetic proteins for articular cartilage regeneration. Osteoarthritis Cartilage. 2018; 26(9):1153-1161. DOI: 10.1016/j.joca.2018.03.007. View

15.

de Souza Tolentino E, de Castro T, Michellon F, Passoni A, Ortega L, Iwaki L . Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: Systematic review. Head Neck. 2019; 41(12):4209-4228. DOI: 10.1002/hed.25944. View

16.

Novais A, Chatzopoulou E, Chaussain C, Gorin C . The Potential of FGF-2 in Craniofacial Bone Tissue Engineering: A Review. Cells. 2021; 10(4). PMC: 8073160. DOI: 10.3390/cells10040932. View

17.

Muallah D, Sembdner P, Holtzhausen S, Meissner H, Hutsky A, Ellmann D . Adapting the Pore Size of Individual, 3D-Printed CPC Scaffolds in Maxillofacial Surgery. J Clin Med. 2021; 10(12). PMC: 8233728. DOI: 10.3390/jcm10122654. View

18.

Bose S, Fielding G, Tarafder S, Bandyopadhyay A . Understanding of dopant-induced osteogenesis and angiogenesis in calcium phosphate ceramics. Trends Biotechnol. 2013; 31(10):594-605. PMC: 3825404. DOI: 10.1016/j.tibtech.2013.06.005. View

19.

Alavi S, Gholami M, Ebrahimi Shahmabadi H, Reher P . Resorbable GBR Scaffolds in Oral and Maxillofacial Tissue Engineering: Design, Fabrication, and Applications. J Clin Med. 2023; 12(22). PMC: 10672220. DOI: 10.3390/jcm12226962. View

20.

Kong X, Zheng T, Wang Z, Zhou T, Shi J, Wang Y . Remote actuation and on-demand activation of biomaterials pre-incorporated with physical cues for bone repair. Theranostics. 2024; 14(11):4438-4461. PMC: 11303086. DOI: 10.7150/thno.97610. View